PKUMDL-WQ-2101
PKUMDL-WQ-2101 is a non-NAD+-competing allosteric phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 34.8 μM. PKUMDL-WQ-2101 exhibits antitumor activity[1].
Product Specifications
CAS Number
[304481-72-9]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Phosphoglycerate Dehydrogenase (PHGDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pkumdl-wq-2101.html
Purity
99.94
Solubility
DMSO : 116.67 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C(C=C1O)O)N/N=C/C2=CC([N+]([O-])=O)=CC=C2O
Molecular Formula
C14H11N3O6
Molecular Weight
317.25
Precautions
H315, H319, H335
References & Citations
[1]Qian Wang, et al. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity. Cell Chem Biol. 2017 Jan 19;24 (1) :55-65.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
N2600-37 500 Tests
P-Nitrophenyl Phosphate (pNPP, KR-pT-IRR), Phosphatase BioAssayTM Kit
Sign In for Pricing
View Details 
GL806g each
Brain glioblastoma (most of GBM) tissue array with normal brain tissue as control, including WHO histological classification and pathology grade, 40 cases/80 cores (core size 1.5mm), replacing GL806f-GL806g
Sign In for Pricing
View Details